Bamforth Mark R
Director at CDMO; Sr.VP, Corp. Operations & Phar at GENZYME CORP
- Sold, on record
- $4.4M
- Dollars the filings state
- Form 4 sales
- 3
- Latest Mar 17, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- CDMOAvid Bioservices, Inc.Director
- GENZYME CORPSr.VP, Corp. Operations & Phar
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Sales by company
- CDMO126,000 shares
- GENZYME CORP25,677 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale GENZYME CORPUnusualAug 6, 2008 2008
Sold 6,445 shares at $79.00 ($509k)
Bamforth Mark R, Sr.VP, Corp. Operations & Phar
Sold 97.6% of holdings ($522k position)158 shares leftFirst sale on recordFiling
- 2 Form 4 sale GENZYME CORPUnusualAug 14, 2008 +8 days
Sold 19,232 shares at $81.71 ($1.6M)
Bamforth Mark R, Sr.VP, Corp. Operations & Phar
Sold 99.2% of holdings ($1.6M position)158 shares leftFiling
- 3 Form 4 sale CDMOUnusualMar 17, 2021 +4598 days
Sold 126,000 shares at $18.18 ($2.3M)
Bamforth Mark R, Director
Sold 100% of holdings ($2.3M position)0 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2021 | Mar 19, 2021 | CDMO | Director | Form 4 sale | 126,000 | $2.3M | 100.0% | Unusual | SEC |
| Aug 14, 2008 | Aug 15, 2008 | GENZYME CORP | Sr.VP, Corp. Operations & Phar | Form 4 sale | 19,232 | $1.6M | 99.2% | Unusual | SEC |
| Aug 6, 2008 | Aug 7, 2008 | GENZYME CORP | Sr.VP, Corp. Operations & Phar | Form 4 sale | 6,445 | $509k | 97.6% | Unusual | SEC |